Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Aug;64(8):3007–3015. doi: 10.1128/iai.64.8.3007-3015.1996

Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures.

R J Neill 1, M Jett 1, R Crane 1, J Wootres 1, C Welch 1, D Hoover 1, P Gemski 1
PMCID: PMC174181  PMID: 8757827

Abstract

Site-directed mutagenesis has been used to introduce amino acid substitutions at specific residues of the staphylococcal enterotoxin B (SEB) gene cloned from Staphylococcus aureus 10-275. The mitogenic activities of these derivatives were determined in two assay systems: (i) mouse spleen cells and (ii) a mixture of human peripheral blood mononuclear cells and lymphocytes. Substitution of either His-12, His-32, His-121, His-166, Lys-152, or Gly-205 did not significantly alter the mitogenic activity from that of the wild-type toxin in either proliferation assay. Substitution of either residue Asn-23, Phe-44, or Cys-93 reduced the mitogenicity of SEB by a degree that depended upon the assay system used. Similar to the results reported by others measuring toxin activation of mouse lymphoid cells, we found that substitutions of these three residues of SEB caused at least 800-fold reductions of mitogenic activity from that of the wild-type toxin. When tested for toxicity in vivo in D-galactosamine-treated mice, the reduced activities of these mutant toxins, however, were not as pronounced. In contrast, when tested in the human cell mitogenicity assay, these mutant toxins were active. Small alterations in activity (two- to fivefold reduction) were observable only at low concentrations. Our findings reveal the importance of using human lymphocytes in addition to the traditional mouse spleen cell assay when assessing biological activities of staphylococcal enterotoxins.

Full Text

The Full Text of this article is available as a PDF (309.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alber G., Hammer D. K., Fleischer B. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J Immunol. 1990 Jun 15;144(12):4501–4506. [PubMed] [Google Scholar]
  2. Betley M. J., Borst D. W., Regassa L. B. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol. 1992;55:1–35. [PubMed] [Google Scholar]
  3. Blanco L., Choi E. M., Connolly K., Thompson M. R., Bonventre P. F. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun. 1990 Sep;58(9):3020–3028. doi: 10.1128/iai.58.9.3020-3028.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bonventre P. F., Heeg H., Cullen C., Lian C. J. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun. 1993 Mar;61(3):793–799. doi: 10.1128/iai.61.3.793-799.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boyle T., Lancaster V., Hunt R., Gemski P., Jett M. Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonate metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice. Anal Biochem. 1994 Feb 1;216(2):373–382. doi: 10.1006/abio.1994.1055. [DOI] [PubMed] [Google Scholar]
  6. Brunson K. W., Watson D. W. Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin. Infect Immun. 1974 Aug;10(2):347–351. doi: 10.1128/iai.10.2.347-351.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buelow R., O'Hehir R. E., Schreifels R., Kummerehl T. J., Riley G., Lamb J. R. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J Immunol. 1992 Jan 1;148(1):1–6. [PubMed] [Google Scholar]
  8. CLARK W. G., BORISON H. L. PYROGENIC EFFECT OF PURIFIED STAPHYLOCOCCAL ENTEROTOXIN. J Pharmacol Exp Ther. 1963 Nov;142:237–241. [PubMed] [Google Scholar]
  9. Chatterjee S., Jett M. Glycosphingolipids: the putative receptor for Staphylococcus aureus enterotoxin-B in human kidney proximal tubular cells. Mol Cell Biochem. 1992 Jul 6;113(1):25–31. doi: 10.1007/BF00230882. [DOI] [PubMed] [Google Scholar]
  10. Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Drynda A., König B., Bonventre P. F., König W. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect Immun. 1995 Mar;63(3):1095–1101. doi: 10.1128/iai.63.3.1095-1101.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grossman D., Lamphear J. G., Mollick J. A., Betley M. J., Rich R. R. Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun. 1992 Dec;60(12):5190–5196. doi: 10.1128/iai.60.12.5190-5196.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grossman D., Van M., Mollick J. A., Highlander S. K., Rich R. R. Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol. 1991 Nov 15;147(10):3274–3281. [PubMed] [Google Scholar]
  14. Harris T. O., Betley M. J. Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect Immun. 1995 Jun;63(6):2133–2140. doi: 10.1128/iai.63.6.2133-2140.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harris T. O., Grossman D., Kappler J. W., Marrack P., Rich R. R., Betley M. J. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun. 1993 Aug;61(8):3175–3183. doi: 10.1128/iai.61.8.3175-3183.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harris T. O., Hufnagle W. O., Betley M. J. Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation. Infect Immun. 1993 May;61(5):2059–2068. doi: 10.1128/iai.61.5.2059-2068.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hayball J. D., Robinson J. H., O'Hehir R. E., Verhoef A., Lamb J. R., Lake R. A. Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR V beta gene products. Int Immunol. 1994 Feb;6(2):199–211. doi: 10.1093/intimm/6.2.199. [DOI] [PubMed] [Google Scholar]
  18. Hedlund G., Dohlsten M., Herrmann T., Buell G., Lando P. A., Segrén S., Schrimsher J., MacDonald H. R., Sjögren H. O., Kalland T. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol. 1991 Dec 15;147(12):4082–4085. [PubMed] [Google Scholar]
  19. Hoffmann M. L., Jablonski L. M., Crum K. K., Hackett S. P., Chi Y. I., Stauffacher C. V., Stevens D. L., Bohach G. A. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun. 1994 Aug;62(8):3396–3407. doi: 10.1128/iai.62.8.3396-3407.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hovde C. J., Marr J. C., Hoffmann M. L., Hackett S. P., Chi Y. I., Crum K. K., Stevens D. L., Stauffacher C. V., Bohach G. A. Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol Microbiol. 1994 Sep;13(5):897–909. doi: 10.1111/j.1365-2958.1994.tb00481.x. [DOI] [PubMed] [Google Scholar]
  21. Hudson K. R., Robinson H., Fraser J. D. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity. J Exp Med. 1993 Jan 1;177(1):175–184. doi: 10.1084/jem.177.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Iandolo J. J. Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu Rev Microbiol. 1989;43:375–402. doi: 10.1146/annurev.mi.43.100189.002111. [DOI] [PubMed] [Google Scholar]
  23. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  24. Jett M., Brinkley W., Neill R., Gemski P., Hunt R. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun. 1990 Nov;58(11):3494–3499. doi: 10.1128/iai.58.11.3494-3499.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jett M., Neill R., Welch C., Boyle T., Bernton E., Hoover D., Lowell G., Hunt R. E., Chatterjee S., Gemski P. Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect Immun. 1994 Aug;62(8):3408–3415. doi: 10.1128/iai.62.8.3408-3415.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jones C. L., Khan S. A. Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus. J Bacteriol. 1986 Apr;166(1):29–33. doi: 10.1128/jb.166.1.29-33.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kappler J. W., Herman A., Clements J., Marrack P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med. 1992 Feb 1;175(2):387–396. doi: 10.1084/jem.175.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kreiswirth B. N., Löfdahl S., Betley M. J., O'Reilly M., Schlievert P. M., Bergdoll M. S., Novick R. P. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983 Oct 20;305(5936):709–712. doi: 10.1038/305709a0. [DOI] [PubMed] [Google Scholar]
  29. Langford M. P., Stanton G. J., Johnson H. M. Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun. 1978 Oct;22(1):62–68. doi: 10.1128/iai.22.1.62-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lee P. K., Kreiswirth B. N., Deringer J. R., Projan S. J., Eisner W., Smith B. L., Carlson E., Novick R. P., Schlievert P. M. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J Infect Dis. 1992 Jun;165(6):1056–1063. doi: 10.1093/infdis/165.6.1056. [DOI] [PubMed] [Google Scholar]
  31. Mahana W., al-Daccak R., Lévéillé C., Valet J. P., Hébert J., Ouellette M., Mourad W. A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity. Infect Immun. 1995 Aug;63(8):2826–2832. doi: 10.1128/iai.63.8.2826-2832.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Marr J. C., Lyon J. D., Roberson J. R., Lupher M., Davis W. C., Bohach G. A. Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications. Infect Immun. 1993 Oct;61(10):4254–4262. doi: 10.1128/iai.61.10.4254-4262.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Marrack P., Blackman M., Kushnir E., Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med. 1990 Feb 1;171(2):455–464. doi: 10.1084/jem.171.2.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  35. McCormack J. E., Callahan J. E., Kappler J., Marrack P. C. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol. 1993 May 1;150(9):3785–3792. [PubMed] [Google Scholar]
  36. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P. H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992 Jan 1;175(1):91–98. doi: 10.1084/jem.175.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mollick J. A., McMasters R. L., Grossman D., Rich R. R. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med. 1993 Feb 1;177(2):283–293. doi: 10.1084/jem.177.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Murray D. L., Prasad G. S., Earhart C. A., Leonard B. A., Kreiswirth B. N., Novick R. P., Ohlendorf D. H., Schlievert P. M. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. J Immunol. 1994 Jan 1;152(1):87–95. [PubMed] [Google Scholar]
  39. Neill R. J., Fanning G. R., Delahoz F., Wolff R., Gemski P. Oligonucleotide probes for detection and differentiation of Staphylococcus aureus strains containing genes for enterotoxins A, B, and C and toxic shock syndrome toxin 1. J Clin Microbiol. 1990 Jul;28(7):1514–1518. doi: 10.1128/jcm.28.7.1514-1518.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S263–S269. doi: 10.1093/clinids/11.supplement_1.s263. [DOI] [PubMed] [Google Scholar]
  41. Peavy D. L., Adler W. H., Smith R. T. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol. 1970 Dec;105(6):1453–1458. [PubMed] [Google Scholar]
  42. Pontzer C. H., Russell J. K., Johnson H. M. Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol. 1989 Jul 1;143(1):280–284. [PubMed] [Google Scholar]
  43. Prasad G. S., Earhart C. A., Murray D. L., Novick R. P., Schlievert P. M., Ohlendorf D. H. Structure of toxic shock syndrome toxin 1. Biochemistry. 1993 Dec 21;32(50):13761–13766. doi: 10.1021/bi00213a001. [DOI] [PubMed] [Google Scholar]
  44. Ranelli D. M., Jones C. L., Johns M. B., Mussey G. J., Khan S. A. Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5850–5854. doi: 10.1073/pnas.82.17.5850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reck B., Scheuber P. H., Londong W., Sailer-Kramer B., Bartsch K., Hammer D. K. Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies. Proc Natl Acad Sci U S A. 1988 May;85(9):3170–3174. doi: 10.1073/pnas.85.9.3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. SUGIYAMA H., MCKISSIC E. M., Jr, BERGDOLL M. S., HELLER B. ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN. J Infect Dis. 1964 Apr;114:111–118. doi: 10.1093/infdis/114.2.111. [DOI] [PubMed] [Google Scholar]
  47. Schantz E. J., Roessler W. G., Wagman J., Spero L., Dunnery D. A., Bergdoll M. S. Purification of staphylococcal enterotoxin B. Biochemistry. 1965 Jun;4(6):1011–1016. doi: 10.1021/bi00882a005. [DOI] [PubMed] [Google Scholar]
  48. Schlievert P. M. Role of superantigens in human disease. J Infect Dis. 1993 May;167(5):997–1002. doi: 10.1093/infdis/167.5.997. [DOI] [PubMed] [Google Scholar]
  49. Scholl P. R., Trede N., Chatila T. A., Geha R. S. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1. J Immunol. 1992 Apr 1;148(7):2237–2241. [PubMed] [Google Scholar]
  50. Sero L., Metzger J. F., Warren J. R., Griffin B. Y. Biological activity and complementation of the two peptides of staphylococcal enterotoxin B formed by limited tryptic hydrolysis. J Biol Chem. 1975 Jul 10;250(13):5026–5032. [PubMed] [Google Scholar]
  51. Smith B. G., Johnson H. M. The effect of staphylococcal enterotoxins on the primary in vitro immune response. J Immunol. 1975 Aug;115(2):575–578. [PubMed] [Google Scholar]
  52. Spero L., Morlock B. A., Metzger J. F. On the cross-reactivity of staphylococcal enterotoxins A, B, and C. J Immunol. 1978 Jan;120(1):86–89. [PubMed] [Google Scholar]
  53. Strickler M. P., Neill R. J., Stone M. J., Hunt R. E., Brinkley W., Gemski P. Rapid purification of staphylococcal enterotoxin B by high-pressure liquid chromatography. J Clin Microbiol. 1989 May;27(5):1031–1035. doi: 10.1128/jcm.27.5.1031-1035.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801–806. doi: 10.1038/359801a0. [DOI] [PubMed] [Google Scholar]
  55. Swaminathan S., Furey W., Pletcher J., Sax M. Residues defining V beta specificity in staphylococcal enterotoxins. Nat Struct Biol. 1995 Aug;2(8):680–686. doi: 10.1038/nsb0895-680. [DOI] [PubMed] [Google Scholar]
  56. Uchiyama T., Kamagata Y., Yan X. J., Kawachi A., Fujikawa H., Igarashi H., Okubo M. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells. Clin Exp Immunol. 1989 Feb;75(2):239–244. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES